LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk

British Journal of Cancer

Volumn 110, Issue 8, 2014, Pages 2123-2130

  Tajuddin, S M ^a   Amaral, A F S ^a   Fernandez A F ^b   Chanock, S ^c   Silverman, D T ^c   Tardon A ^d,e   Carrato, A ^f,g   Garcia Closas M ^h   Jackson, B P ⁱ   Torano E G ^b   Marquez M ^a   Urdinguio, R G ^b   Garcia Closas R ^j   Rothman, N ^c   Kogevinas, M ^k   Real, F X ^a,l   Fraga, M F ^b,m   Malats, N ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF OVIEDO   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ Dartmouth College   (United States)

^j HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^k CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^l UNIVERSITAT POMPEU FABRA   (Spain)

^m CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LEUKOCYTE DNA; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA STRUCTURE; DOMINANT INHERITANCE; ENVIRONMENTAL FACTOR; FEMALE; GENETIC VARIABILITY; HEREDITY; HOMOZYGOSITY; HUMAN; LONG INTERSPERSED NUCLEAR ELEMENT 1; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; BLADDER TUMOR; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING; LEUKOCYTE; LONG INTERSPERSED REPEAT; MIDDLE AGED; PATHOLOGY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CPG ISLANDS; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LEUKOCYTES; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84901953680     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.67     Document Type: Article

References (46)

1. Amaral AF, Porta M, Silverman DT, Milne RL, Kogevinas M, Rothman N, Cantor KP, Jackson BP, Pumarega JA, Lopez T, Carrato A, Guarner L, Real FX, Malats N (2011) Pancreatic cancer risk and levels of trace elements. Gut 61(11): 1583-1588
2. Cash HL, Tao L, Yuan JM, Marsit CJ, Houseman EA, Xiang YB, Gao YT, Nelson HH, Kelsey KT (2012) LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int J Cancer 130(5): 1151-1159
3. Choi SH, Worswick S, Byun HM, Shear T, Soussa JC, Wolff EM, Douer D, Garcia-Manero G, Liang G, Yang AS (2009) Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer. Int J Cancer 125(3): 723-729
4. Chuang SC, Stolzenberg-Solomon R, Ueland PM, Vollset SE, Midttun O, Olsen A, Tjonneland A, Overvad K, Boutron-Ruault MC, Morois S, Clavel-Chapelon F, Teucher B, Kaaks R, Weikert C, Boeing H, Trichopoulou A, Benetou V, Naska A, Jenab M, Slimani N, Romieu I, Michaud DS, Palli D, Sieri S, Panico S, Sacerdote C, Tumino R, Skeie G, Duell EJ, Rodriguez L, Molina-Montes E, Huerta JM, Larranaga N, Gurrea AB, Johansen D, Manjer J, Ye W, Sund M, Peeters PH, Jeurnink S, Wareham N, Khaw KT, Crowe F, Riboli E, Bueno-de-Mesquita B, Vineis P (2011) A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer 47(12): 1808-1816
5. Estecio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang TH, Tajara EH, Issa JP (2007) LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2(5): e399
6. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358(11): 1148-1159
7. Florl AR, Schulz WA (2008) Chromosomal instability in bladder cancer. Arch Toxicol 82(3): 173-182
8. Garcia-Closas M, Malats N, Real FX, Yeager M, Welch R, Silverman D, Kogevinas M, Dosemeci M, Figueroa J, Chatterjee N, Tardon A, Serra C, Carrato A, Garcia-Closas R, Murta-Nascimento C, Rothman N, Chanock SJ (2007a) Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 3(2): e29
9. Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Castano-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Tora M, Fernandez F, Real FX, Rothman N (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366(9486): 649-659
10. Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Malats N, Dinney CP, Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, Albanes D, Purdue MP, Kogevinas M, Kamat AM, Lerner SP, Grossman HB, Gu J, Pu X, Hutchinson A, Fu YP, Burdett L, Yeager M, Tang W, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole Jr. G, Grubb III R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Fraumeni Jr. JF, Silverman DT, Chanock SJ, Wu X (2011) A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet 20(21): 4282-4289
11. Garcia-Closas R, Garcia-Closas M, Kogevinas M, Malats N, Silverman D, Serra C, Tardon A, Carrato A, Castano-Vinyals G, Dosemeci M, Moore L, Rothman N, Sinha R (2007b) Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer 43(11): 1731-1740
12. Glunde K, Bhujwalla ZM, Ronen SM (2011) Choline metabolism in malignant transformation. Nat Rev Cancer 11(12): 835-848
13. Hopkins WA, Staub BP, Baionno JA, Jackson BP, Roe JH, Ford NB (2004) Trophic and maternal transfer of selenium in brown house snakes (Lamprophis fuliginosus). Ecotoxicol Environ Saf 58(3): 285-293
14. Izarzugaza MI, Ardanaz E, Chirlaque MD, Font C, Ameijide A, Linares C (2010) Tobacco-related tumours of the lung, bladder and larynx: changes in Spain. Ann Oncol 21(Suppl 3): iii52-iii60
15. Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13(7): 484-492
16. Jurgens B, Schmitz-Drager BJ, Schulz WA (1996) Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res 56(24): 5698-5703
17. Laird PW (2010) Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 11(3): 191-203
18. Lee YL, Xu X, Wallenstein S, Chen J (2009) Gene expression profiles of the one-carbon metabolism pathway. J Genet Genomics 36(5): 277-282
19. Liao LM, Brennan P, van Bemmel DM, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Rothman N, Boffetta P, Chow WH, Moore LE (2011) LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer. PLoS One 6(11): e27361
20. Lopez-Knowles E, Hernandez S, Malats N, Kogevinas M, Lloreta J, Carrato A, Tardon A, Serra C, Real FX (2006) PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Res 66(15): 7401-7404
21. Lotan Y, Svatek RS, Malats N (2008) Screening for bladder cancer: a perspective. World J Urol 26(1): 13-18
22. Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, Garcia-Closas R, Silverman D, Chanock S, Welch R, Tardon A, Serra C, Carrato A, Dosemeci M, Garcia-Closas M (2007) Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 120(11): 2452-2458
23. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, Silverman D, Garcia-Closas R, Chanock S, Tardon A, Serra C, Carrato A, Dosemeci M, Garcia-Closas M, Esteller M, Fraga M, Rothman N, Malats N (2008) Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 9(4): 359-366
24. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX, Malats N (2007) Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 25(3): 285-295
25. Parkin DM (2008) The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl (218): 12-20
26. Phokaew C, Kowudtitham S, Subbalekha K, Shuangshoti S, Mutirangura A (2008) LINE-1 methylation patterns of different loci in normal and cancerous cells. Nucleic Acids Res 36(17): 5704-5712
27. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole Jr. G, Grubb III R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D Garciá-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni Jr. JF, Silverman DT, Chanock SJ (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42(11): 978-984
28. Royston P, Sauerbrei W (2007) Multivariable modeling with cubic regression splines: a principled approach. Stata J 7(1): 45-70
29. Salonia A, Abdollah F, Capitanio U, Suardi N, Briganti A, Gallina A, Colombo R, Ferrari M, Castagna G, Rigatti P, Montorsi F (2012) Serum sex steroids depict a nonlinear u-shaped association with highrisk prostate cancer at radical prostatectomy. Clin Cancer Res 18(13): 3648-3657
30. Samanic C, Kogevinas M, Dosemeci M, Malats N, Real FX, Garcia-Closas M, Serra C, Carrato A, Garcia-Closas R, Sala M, Lloreta J, Tardon A, Rothman N, Silverman DT (2006) Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 15(7): 1348-1354
31. Skinner HG, Gangnon RE, Litzelman K, Johnson RA, Chari ST, Petersen GM, Boardman LA (2012) Telomere length and pancreatic cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 21(11): 2095-2100
32. Taby R, Issa JP (2010) Cancer epigenetics. CA Cancer J Clin 60(6): 376-392
33. Tost J, Gut IG (2007) DNA methylation analysis by pyrosequencing. Nat Protoc 2(9): 2265-2275
34. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108(1): 104-108
35. Ueland PM (2011) Choline and betaine in health and disease. J Inherit Metab Dis 34(1): 3-15
36. Ulrey CL, Liu L, Andrews LG, Tollefsbol TO (2005) The impact of metabolism on DNA methylation. Hum Mol Genet 14(Spec No 1): R139-R147
37. van Bemmel D, Lenz P, Liao LM, Baris D, Sternberg LR, Warner AC, Johnson AT, Jones MA, Kida M, Schwenn M, Schned A, Silverman DT, Rothman N, Moore LE (2012) Correlation of LINE-1 methylation levels in patient matched buffy coat, serum, buccal cell and bladder tumor tissue DNA samples. Cancer Epidemiol Biomarkers Prev 21(7): 1143-1148
38. Vance DE, Li Z, Jacobs RL (2007) Hepatic phosphatidylethanolamine N-methyltransferase, unexpected roles in animal biochemistry and physiology. J Biol Chem 282(46): 33237-33241
39. Volanis D, Kadiyska T, Galanis A, Delakas D, Logotheti S, Zoumpourlis V (2010) Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicol Lett 193(2): 131-137
40. Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, Zens MS, Andrew AS, Morris S, Nelson HH, Schned AR, Karagas MR, Marsit CJ (2010) Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 16(5): 1682-1689
41. Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G (2010) Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 6(4): e1000917
42. Woo HD, Kim J (2012) Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One 7(4): e34615
43. Wu HC, Delgado-Cruzata L, Flom JD, Kappil M, Ferris JS, Liao Y, Santella RM, Terry MB (2011) Global methylation profiles in DNA from different blood cell types. Epigenetics 6(1): 76-85
44. Wu XR (2005) Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5(9): 713-725
45. Xu X, Gammon MD, Zeisel SH, Lee YL, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J (2008) Choline metabolism and risk of breast cancer in a population-based study. FASEB J 22(6): 2045-2052
46. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32(3): e38.